Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulation With Apixaban”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03129555
What this trial is testing

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Herlev and Gentofte Hospital 5,000
Not applicableStudy completedNCT04818151
What this trial is testing

Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data

Who this might be right for
Venous Thromboembolic DiseaseKidney Failure, Chronic
Johns Hopkins University 14,914
Large-scale testing (Phase 3)Not Yet RecruitingNCT06045858
What this trial is testing

Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)

Who this might be right for
Atrial FibrillationPeritoneal Dialysis Complication
University Hospital, Caen 178
Not applicableStudy completedNCT02640222
What this trial is testing

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 321,501
Not applicableStudy completedNCT02769078
What this trial is testing

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 14,201
Post-approval studies (Phase 4)Study completedNCT02789917
What this trial is testing

APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF

Who this might be right for
Acute Coronary SyndromeAtrial FibrillationCoronary Artery Disease
LMU Klinikum 403
Post-approval studies (Phase 4)Looking for participantsNCT06571149
What this trial is testing

Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Who this might be right for
Ischemic Stroke
Insel Gruppe AG, University Hospital Bern 906
Post-approval studies (Phase 4)Study completedNCT02942407
What this trial is testing

Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationEnd Stage Renal Disease
Christopher Granger, MD 154
Post-approval studies (Phase 4)Study completedNCT02958969
What this trial is testing

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Who this might be right for
Venous ThromboembolismMultiple Myeloma
Gregory Piazza 50
Early research (Phase 1)Study completedNCT02270918
What this trial is testing

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Who this might be right for
Thrombosis
Thomas Jefferson University 12
Testing effectiveness (Phase 2)UnknownNCT05088928
What this trial is testing

Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care

Who this might be right for
COVID-19
Scotmann Pharmaceuticals 40
Not applicableStudy completedNCT04828772
What this trial is testing

Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

Who this might be right for
COVID-19
Bristol-Myers Squibb 9,282
Post-approval studies (Phase 4)Study completedNCT02100228
What this trial is testing

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Who this might be right for
Atrial Fibrillation
Pfizer 1,500
Post-approval studies (Phase 4)UnknownNCT04344717
What this trial is testing

Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition

Who this might be right for
Short Bowel SyndromeAnticoagulation
Universitaire Ziekenhuizen KU Leuven 84
Large-scale testing (Phase 3)Study completedNCT02207725
What this trial is testing

A Study in Older Subjects to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Apixaban

Who this might be right for
Bleeding
Portola Pharmaceuticals 68
Post-approval studies (Phase 4)Active Not RecruitingNCT03129490
What this trial is testing

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationAtrial Flutter
Herlev and Gentofte Hospital 11,000
Not applicableStudy completedNCT04618913
What this trial is testing

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Who this might be right for
NeoplasmsEmbolism
Pfizer 1
Testing effectiveness (Phase 2)Looking for participantsNCT07175428
What this trial is testing

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Who this might be right for
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals 1,200
Not applicableStudy completedNCT05038228
What this trial is testing

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Who this might be right for
Atrial Fibrillation
Pfizer 1
Not applicableLooking for participantsNCT06556446
What this trial is testing

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Who this might be right for
Ischemic Stroke
Insel Gruppe AG, University Hospital Bern 2,800
Next Page